Nanomedicines and Vaccines
NANO-VAC
Hospital Clinic Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (34)
2024
-
Biomarkers predicting the controller dose of omalizumab in patients with chronic spontaneous urticaria
Clinical and Experimental Allergy, Vol. 54, Núm. 6, pp. 402-411
2022
-
Consensus on the Definition of Control and Remission in Chronic Urticaria
Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 4, pp. 261-269
-
Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 6, pp. 1736-1750
-
Validation of a commercial allergen microarray platform for specific immunoglobulin E detection of respiratory and plant food allergens
Annals of Allergy, Asthma and Immunology, Vol. 128, Núm. 3, pp. 283-290.e4
2021
-
Aradyal: The spanish multidisciplinary research network for allergic diseases
Journal of Investigational Allergology and Clinical Immunology, Vol. 31, Núm. 2, pp. 108-119
2020
-
Diagnostic capacity of commercial extracts vs prick-by-prick in the study of sensitization to peanut: Which technique should we use?
Journal of Investigational Allergology and Clinical Immunology, Vol. 30, Núm. 5, pp. 373-375
-
Identification and Characterization of IgE-Reactive Proteins and a New Allergen (Cic a 1.01) from Chickpea (Cicer arietinum)
Molecular Nutrition and Food Research, Vol. 64, Núm. 19
2019
-
Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study)
Health and Quality of Life Outcomes, Vol. 17, Núm. 1
2017
-
Allergy rhinitis: Similarities and differences between children and adults
Rhinology, Vol. 55, Núm. 4, pp. 326-331
-
Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells
Scientific Reports, Vol. 7, Núm. 1
2016
-
Allergic rhinitis causes loss of smell in children: The OLFAPEDRIAL study
Pediatric Allergy and Immunology, Vol. 27, Núm. 8, pp. 867-870
-
Comparable actions of omalizumab on mast cells and basophils
Clinical and Experimental Allergy, Vol. 46, Núm. 1, pp. 92-102
2015
-
Management of urticaria: Not too complicated, not too simple
Clinical and Experimental Allergy, Vol. 45, Núm. 4, pp. 731-743
2014
-
Assessment of severity and quality of life in chronic urticaria
Journal of Investigational Allergology and Clinical Immunology, Vol. 24, Núm. 2, pp. 80-86
2013
-
Analysis of comorbidities and therapeutic approach for allergic rhinitis in a pediatric population in Spain
Pediatric Allergy and Immunology, Vol. 24, Núm. 7, pp. 678-684
-
Bilastine for the treatment of urticaria
Expert Opinion on Pharmacotherapy, Vol. 14, Núm. 11, pp. 1537-1544
-
Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: Analysis of 110 patients in real-life practice
Expert Opinion on Biological Therapy, Vol. 13, Núm. 9, pp. 1225-1228
2012
-
Validation of the modified allergic rhinitis and its impact on asthma (ARIA) severity classification in allergic rhinitis children: The PEDRIAL study
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 67, Núm. 11, pp. 1437-1442
2011
-
Effect of bilastine upon the ocular symptoms of allergic rhinoconjunctivitis.
Journal of investigational allergology & clinical immunology : official organ of the International Association of Asthmology (INTERASMA) and Sociedad Latinoamericana de Alergia e Inmunología, Vol. 21 Suppl 3, pp. 24-33
-
Validation of ARIA (Allergic Rhinitis and its Impact on Asthma) classification in a pediatric population: The PEDRIAL study
Pediatric Allergy and Immunology, Vol. 22, Núm. 4, pp. 388-392